Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 178.44 Million | USD 370.61 Million | 8.46% | 2023 |
The non-invasive glucose meter market size was worth around USD 178.44 Million in 2023 and is predicted to grow to around USD 370.61 Million by 2032 with a compound annual growth rate (CAGR) of roughly 8.46% between 2024 and 2032.
The report covers forecast and analysis for the non-invasive glucose meter market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the non-invasive glucose meter market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the non-invasive glucose meter market on a global level.
There is a device known as a non-invasive glucose meter that is meant to monitor the levels of glucose in the blood without the requirement for a blood sample to be taken. Utilising cutting-edge technology such as infrared spectroscopy, ultrasound, or electromagnetic sensors, non-invasive glucose meters are able to detect glucose levels via the skin, in contrast to typical glucose meters, which require a finger prick to get a drop of blood. When it comes to monitoring their blood sugar levels on a daily basis, these gadgets provide a method that is both more comfortable and convenient for individuals, particularly those who currently have diabetes. Non-invasive glucose meters are being developed with the intention of enhancing patient compliance, minimising discomfort, and delivering continuous or on-demand glucose monitoring without the discomfort and inconvenience that are typically associated with conventional measuring methods.
Worldwide demand for minimal invasive devices is growing at a rapid pace. Global demand for non-invasive glucose meter is expected to be driven by increasing prevalence of diabetes across the globe owing to changing lifestyle habits, sedentary lifestyle, lack of physical activity, changing eating habits, genetic factors, etc. Continuous glucose monitoring has become an utmost importance in diabetic population in order to avoid high blood glucose levels and related complexities. Additionally, increasing preference for non-invasive continuous glucose monitoring, growing health awareness, and wide adoption of technologically advanced products are expected to be major factors attributing to the growth of non-invasive glucose meter market. However, high prices of non-invasive glucose meter and stringent regulatory requirements may act as a restraint for non-invasive glucose meter market growth. Emerging countries and increasing geriatric population are expected to bring new growth opportunities for non-invasive glucose meter market.
Based on type, the market is segmented into wearable device, handheld, and other types. Handheld type segment held the largest market share in 2023 whereas the wearable device type segment is expected witness highest CAGR during the forecast period. Wearable devices offer continuous glucose monitoring and can be used without any inconvenience by the user thus promoting the growth rate of the market in the coming years.
Based on technology, market is segmented into Raman Spectroscopy, Near Infrared Spectroscopy (NIRS), Photo-acoustic Spectroscopy (PA), Optical Coherence Tomography (OCT), Mid -Infrared Spectroscopy (Mid-IRS) and Other Technologies.
Based On End-users, Hospitals and clinics, home care settings, and others are the end-users of the non-invasive glucose meter market. Hospitals and clinics end-user segment dominated the market in terms of revenue in 2023 owing to the growing adoption of cutting edge products to deliver advanced health care services to patients and availability of large patient pool. Home care settings end-user segment is expected to witness highest growth rate over the forecast period.
Report Attributes | Report Details |
---|---|
Report Name | Non-Invasive Glucose Meter Market |
Market Size in 2023 | USD 178.44 Million |
Market Forecast in 2032 | USD 370.61 Million |
Growth Rate | CAGR of 8.46% |
Number of Pages | 110 |
Key Companies Covered | Animas Technologies, Abbott, Life Scan, Bayer Healthcare, Pendragon Medical, Cercacor, Biophotonic Corporation, DexCom, OrSense, MediWise, Integrity Applications Incorporate, Cnoga Care, Roche Diagnostics and Nemaura Medical Inc. among others |
Segments Covered | By Type, By Technology, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America dominated the global non-invasive glucose meter market and accounted for almost 42% market share in 2023. North America region is projected to lead the market over the forecast period with growth mostly concentrated in the U.S. market. Increasing prevalence of diabetes, increasing geriatric population, presence of major manufacturers in this region are major factors that attribute to largest revenue share. Europe was the second largest non-invasive glucose meter market in 2023 globally. Favorable reimbursement policies, surge in demand for cutting edge non-invasive products for continuous glucose monitoring, increasing diabetic population base are other major factors driving the demand for non-invasive glucose meter in Europe. Asia Pacific is estimated to be growing at the highest CAGR in the coming years. Rapid growth in this region is attributable to increasing diabetic population, growing health awareness among patients, growth in geriatric population in emerging economies like China and India, etc. Latin America is projected to grow moderately, however poor healthcare infrastructure in the Middle East and Africa will lead to slow market growth.
Some of the key players in non-invasive glucose meter market include
Global Non-Invasive Glucose Meter Market: By Type
Global Non-Invasive Glucose Meter Market: By Technology
Global Non-Invasive Glucose Meter Market: By End-User
Global Non-Invasive Glucose Meter Market: By Region
FrequentlyAsked Questions
A non-invasive glucose meter is a device designed to measure blood glucose levels without the need for a blood sample. Unlike traditional glucose meters that require a finger prick to obtain a drop of blood, non-invasive glucose meters use advanced technologies such as infrared spectroscopy, ultrasound, or electromagnetic sensors to detect glucose levels through the skin. These devices offer a more comfortable and convenient way for individuals, particularly those with diabetes, to monitor their blood sugar levels regularly. The development of non-invasive glucose meters aims to improve patient compliance, reduce discomfort, and provide continuous or on-demand glucose monitoring without the pain and hassle associated with traditional methods.
Worldwide demand for minimal invasive devices is growing at a rapid pace. Global demand for non-invasive glucose meter is expected to be driven by increasing prevalence of diabetes across the globe owing to changing lifestyle habits, sedentary lifestyle, lack of physical activity, changing eating habits, genetic factors, etc.
According to a study, the global non-invasive glucose meter Industry size was $178.44 Million in 2023 and is projected to reach $370.61 Million by the end of 2032.
The global non-invasive glucose meter market is expected to grow at a CAGR of 8.46% during the forecast period.
North America dominated the global non-invasive glucose meter market and accounted for almost 42% market share in 2023. North America region is projected to lead the market over the forecast period with growth mostly concentrated in the U.S. market.
Some of the key players in non-invasive glucose meter market include Animas Technologies, Abbott, Life Scan, Bayer Healthcare, Pendragon Medical, Cercacor, Biophotonic Corporation, DexCom, OrSense, MediWise, Integrity Applications Incorporate, Cnoga Care, Roche Diagnostics and Nemaura Medical Inc. among others.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed